[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365989-105":59,"doc-detail-365989-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-of-oncogenic-role-of-magoh-and-experiment-validation-in-hepatocellular-carcinoma","Pan-cancer analysis of oncogenic role of MAGOH and experiment validation in hepatocellular carcinoma","","Pan-cancer analysis investigates the oncogenic role of Mago-nashi homolog (MAGOH) with emphasis on hepatocellular carcinoma (HCC). Using diverse bioinformatic databases, the study assesses MAGOH expression and significance across pan-cancer and links it to clinical outcomes. Validation combines clinical specimens and in vitro experiments to confirm MAGOH clinical relevance and biological function. Results show frequent MAGOH overexpression in tumors versus adjacent non-cancer tissues and associations between high MAGOH levels and worse overall and disease-related survival in selected malignancies. MAGOH expression correlates with immune cell infiltration, immune checkpoint expression, tumor mutational burden, microsatellite instability, and mismatch repair status. In HCC tissues, MAGOH is increased compared with non-cancer tissues, correlating with advanced TNM staging and vascular invasion; MAGOH upregulation promotes proliferation, migration, and invasion, while depletion produces opposite effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-oncogenic-role-of-magoh-and-experiment-validation-in-hepatocellular-carcinoma/365989/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-oncogenic-role-of-magoh-and-experiment-validation-in-hepatocellular-carcinoma/365989.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of analyzing MAGOH in this study?","Question",{"text":112,"@type":113},"To clarify MAGOH’s expression patterns and clinical significance across pan-cancer, with a specific focus on hepatocellular carcinoma, and to validate its role experimentally.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study validate MAGOH’s relevance in HCC?",{"text":117,"@type":113},"By using clinical specimens and in vitro experiments to confirm the biological functions suggested by bioinformatic analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did MAGOH show with patient outcomes and tumor features?",{"text":121,"@type":113},"High MAGOH expression was associated with poorer survival metrics in certain cancers, and in HCC it correlated with advanced TNM staging and vascular invasion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365989,1790296573,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPan-cancer analysis of oncogenic role of MAGOH and experiment validation in hepatocellular carcinoma  \nZezhi Qiu1,3, Yi Le1,3, Yanyu Liao1, Xiao Chen1, Xing Xin1, Fengting Nie1, Xianpin Wei1, HengWang2 & Ziling Fang1􀀍  \nSeveral studies have highlighted that Mago-nashi homolog (MAGOH) contributed greatly to cell development, growth, and malignant progression in multiple cancer types. Nevertheless, the  \nrole of MAGOH in pan-cancer datasets, particularly in hepatocellular carcinoma (HCC), remainsuninvestigated. In this study, we first utilized diverse databases to systematically analyze the expression and significance of MAGOH across pan-cancer. Besides, we validated the clinical significance and biological functions of MAGOH in HCC via clinical specimens and in vitro experiments. Bioinformatic analysis has demonstrated that MAGOH was frequently overexpressed in multiple tumors compared to adjacent non-cancerous tissues. Moreover, high expression of MAGOH was related to poorer overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) in certain malignancies, notably an independent prognostic predictor for liver hepatocellular carcinoma (LIHC). Furthermore, MAGOH was closely correlated with immune cell infiltration, immune checkpoint expression, tumor mutational burden (TMB), microsatellite instability (MSI), and mismatch repair (MMR) status. Subsequently, we found that the expression of MAGOH was largely increased in clinical HCC tissues (34/60, 56.7%) compared to non-cancerous tissues. Additionally, MAGOH was positively correlated with advanced TNM staging and vascular invasion. More convincingly, MAGOH upregulation facilitated cell proliferation, migration, and invasion of HCC cells, while MAGOH depletion elicited opposite effects. Collectively, our study conducted a comprehensive analysis of the hitherto undescribed role of MAGOH in pan-cancer by analyzing multi-omics data. More significantly, we recognized MAGOH as a crucial promoter in the malignant progression of hepatocellular carcinoma, providing potential therapeutic targets for HCC patients.  \nKeywords MAGOH (Mago-nashi homolog), Pan-cancer, Hepatocellular carcinoma, Prognosis, Tumor progression  \nAbbreviations  \nMAGOH HCCIHC ROC OS  \nDSSDFI  \nPFILIHC KIPANACC  \nMago-nashi homolog Hepatocellular carcinoma Immunohistochemistry Receiver operating characteristic Overall survival  \nDisease-specific survival Disease-free interval Progression-free interval Liver hepatocellular carcinoma Pan-kidney cohort Adrenocortical carcinoma  \n1Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1519 Dongyue Avenue, Nanchang 330006, Jiangxi Province, People’s Republic of China. 2Department of Orthopedic, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1519 Dongyue Avenue, Nanchang 330006, Jiangxi Province, People’s Republic of China. 3Zezhi Qiu andYi Le contributed equally to this study. 􀀍 email: [ndyfy5399@ncu.edu.cn](ndyfy5399@ncu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nTMB  \nMSI  \nMMR  \nLUAD  \nSTAD  \nIARC  \nTIME  \nEJC  \nHPA  \nTCGA  \nGTEx  \nHR  \nDC  \nFBS  \nSI  \nqRT-PCRcDNACCK-8 EdU  \nBLCA  \nBRCA  \nCESC  \nCHOL  \nCOAD  \nESCA  \nGBM  \nHNSC  \nKIRC  \nKIRP  \nLUSC  \nUCEC  \nKICH  \nTHCA  \nDLBC  \nPAAD  \nPRAD  \nREAD  \nSKCM  \nTGCT  \nTHYM  \nUCS  \nLAML  \nPCPG  \nSARC GBMLGG MESONK cells STESEPCAM RBM8ANMD  \nGC  \nTumor mutational burden Microsatellite instability Mismatch repair  \nLung adenocarcinoma Stomach adenocarcinoma  \nInternational Agency for Research on Cancer Tumor immune microenvironment  \nExon junction complex Human Protein Atlas The Cancer Genome Atlas Genotype-Tissue Expression Hazard ratio  \nDendritic cells Fetal bovine serum Score index  \nQuantitative real-time PCR Complementary DNA Cell Counting Kit-8  \n5-Ethynyl-2 ʹ-deoxyuri","cbCaiv8jIgYavR7x","https://ap.wps.com/l/cbCaiv8jIgYavR7x","pdf",4674911,17,"English","# Background and Rationale\n## Cancer burden and unmet clinical needs\n## Tumor immune microenvironment and therapy resistance\n# MAGOH in Pan-Cancer\n## Genomic location and known functions\n## Expression profiling across cancers\n## Prognostic associations\n# Immunology and Genomic Instability Links\n## Immune cell infiltration\n## Immune checkpoint expression\n## TMB, MSI, and MMR correlations\n# Experimental Validation in HCC\n## Clinical specimen findings\n## Association with TNM stage and vascular invasion\n## Functional assays: proliferation, migration, invasion","[{\"question\":\"What was the main purpose of analyzing MAGOH in this study?\",\"answer\":\"To clarify MAGOH’s expression patterns and clinical significance across pan-cancer, with a specific focus on hepatocellular carcinoma, and to validate its role experimentally.\"},{\"question\":\"How did the study validate MAGOH’s relevance in HCC?\",\"answer\":\"By using clinical specimens and in vitro experiments to confirm the biological functions suggested by bioinformatic analyses.\"},{\"question\":\"What relationship did MAGOH show with patient outcomes and tumor features?\",\"answer\":\"High MAGOH expression was associated with poorer survival metrics in certain cancers, and in HCC it correlated with advanced TNM staging and vascular invasion.\"}]","Pan-cancer analysis of oncogenic role of MAGOH and experiment validation in hepatocellular carcinoma | PDF",1790163421,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abfca61e8935189fe205e0b43a0fb99b.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/757a0d966f62913358d93f48ebed4afd.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/101d6fde478f939fe5007a4fadc43109.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a82c248ae8c981f880238f5540b334c.webp",980,1287]